Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | ECE1 | P42892 | 1/20 | 0.42 |
| ▸ | MME | P08473 | 3/20 | 0.41 |
| ▸ | ACE | P12821 | 2/20 | 0.41 |
| ▸ | CPA1 | P15085 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.39 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.37 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | CIT | O14578 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18712170 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL14347046 | 0.80 | DPP7 (0.39) | DPP4ROCK2DPP7CIT | |
| SCHEMBL17546219 | 0.78 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL540701 | 0.78 | MME (0.53) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL14850398 | 0.78 | MME (0.53) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL24996110 | 0.77 | CYP2D6 (0.43) | LMNAMAPTDPP4ROCK2DPP7 | |
| SCHEMBL12549391 | 0.77 | ALDH1A1 (0.47) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL30861943 | 0.77 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL23836665 | 0.76 | DPP7 (0.39) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL18712169 | 0.76 | DPP7 (0.45) | TDP1DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210337850-A1 | SAVOURY AND MOUTHFULNESS TASTE ENHANCERS | LUCTA, S.A. (ES) | 2021-11-04 | — | — | US | disclosed |
| US-11124525-B2 | Heteroaryl compounds useful as MK2 inhibitors | CELGENE CAR LLC (BM) | 2021-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210337850-A1 | SAVOURY AND MOUTHFULNESS TASTE ENHANCERS | KCNJ6, TAS1R1, TAS2R5 | ALDH1A1 1833/4885LMNA 3556/4885MAPT 4285/4885 |
| US-11124525-B2 | Heteroaryl compounds useful as MK2 inhibitors | MKNK2, MKRN3, MKNK1 | ALDH1A1 4142/4885LMNA 4553/4885MAPT 2463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.